With its second oligonucleotide manufacturing plant now in full operation, ST Pharm is using CPHI Worldwide 2026 in Milan, ...

GI Innovation said Wednesday that its Japanese partner Maruho plans to dose the first patient in a phase 2 trial of allergy ...

Despite major advances in psoriasis treatment, many Korean patients remain undertreated and face social stigma, prompting ...

Children as young as two with Covid-19 can now be treated with Celltrion's intravenous Avtozma in the U.S., following an FDA ...

Less than two weeks after winning U.S. approval for lirafugratinib, HLB is moving the targeted bile duct cancer drug through ...

A police raid on Ajou University Hospital’s pediatric emergency center drew scrutiny at a parliamentary audit Wednesday, ...

GC WellBeing has partnered with obesity treatment specialist 365mc to build clinical evidence and develop treatment protocols ...

Hanyang University Myongji Hospital has partnered with U.S.-based physical AI company Lavoro AI to jointly test and develop ...

CCTV footage showing patients receiving treatment, undergoing procedures and changing clothes at Korean medical institutions ...

Samsung Biologics said on Wednesday it is expanding its drug manufacturing portfolio to capture rising demand for contract manufacturing in Japan.The Korean contract development and manufacturing orga ...

ST Pharm said Tuesday that its investigational HIV-1 drug candidate STP0404 was generally well tolerated in a U.S. phase 2a ...

Korean biotech company Optipharm is accelerating its expansion into xenotransplantation using genetically modified pigs and ...